Anthony G. Quinn
2021
In 2021, Anthony G. Quinn earned a total compensation of $2.6M as Chief Executive Officer at Aeglea BioTherapeutics, a 10% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $332,000 |
|---|---|
| Salary | $560,000 |
| Stock Awards | $1,701,525 |
| Other | $29,661 |
| Total | $2,623,186 |
Quinn received $1.7M in stock awards, accounting for 65% of the total pay in 2021.
Quinn also received $332K in non-equity incentive plan, $560K in salary and $29.7K in other compensation.
Rankings
In 2021, Anthony G. Quinn's compensation ranked 4,971st out of 12,406 executives tracked by ExecPay. In other words, Quinn earned more than 59.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,971 out of 12,406 | 60th |
Division Manufacturing | 2,089 out of 5,494 | 62nd |
Major group Chemicals And Allied Products | 892 out of 2,369 | 62nd |
Industry group Drugs | 799 out of 2,090 | 62nd |
Industry Pharmaceutical Preparations | 568 out of 1,537 | 63rd |
Source: SEC filing on April 21, 2022.
Quinn's colleagues
We found two more compensation records of executives who worked with Anthony G. Quinn at Aeglea BioTherapeutics in 2021.
News
Aeglea BioTherapeutics CEO Anthony Quinn's 2022 pay slips 9% to $2.4M
April 17, 2023
Aeglea BioTherapeutics CEO Anthony Quinn's 2021 pay slips 10% to $2.6M
April 21, 2022
Aeglea BioTherapeutics CEO Anthony Quinn's 2019 pay falls 35% to $2.5M
April 23, 2020
Aeglea BioTherapeutics CEO Anthony Quinn's 2018 pay jumps 274% to $3.8M
April 22, 2019